OpenNeedle Ask your own

Question explored with the scientific record

Conversation so far

  1. 1 What is a normal crp level
  2. 2 What CRP level is considered mildly vs severely elevated, and how?

Answered on this page ↓

What CRP level is considered mildly vs severely elevated, and how?

Sep 8, 2026 · 5 sources used · OpenNeedle synthesis
The short version: there is no single universal cutoff for "mildly" versus "severely" elevated CRP. The categories depend on the clinical context and the specific assay used.

The evidence here does not give a single authoritative table of mild versus severe cutoffs. What it does show is that different studies use different thresholds for different purposes. In community-acquired pneumonia, a CRP above 80 mg/L was used to distinguish bacterial from viral infection, but it performed poorly—only 52% sensitivity [1]. In the same condition, a CRP above 100 mg/L on day 1 was a strong independent predictor of 30-day mortality, with an odds ratio of 42.9 [11]. In pyogenic vertebral osteomyelitis, a CRP above 54.5 mg/L at admission predicted adverse outcomes [19]. In cirrhosis with variceal bleeding, a CRP of 13 mg/L (1.3 mg/dL) was the cutoff for high 6-week mortality in Child-Pugh class C patients [17].

What these numbers tell you is that "mild" and "severe" are not fixed labels. A CRP of 10 mg/L is mildly elevated for a healthy person but severely elevated for someone with cirrhosis. A CRP of 100 mg/L is severely elevated in almost any context. The table below shows the cutoffs used in the retrieved studies and what they predicted.

ContextCutoff (mg/L)What it predictedSource
Healthy adults (hs-CRP)<1 low risk, 1-3 average, >3 highCardiovascular riskGeneral knowledge
Pediatric CAP>80Bacterial vs viral (poor sensitivity)[1]
Adult CAP>100 on day 130-day mortality (OR 42.9)[11]
Pyogenic vertebral osteomyelitis>54.5 at admissionAdverse outcome[19]
Cirrhosis + variceal bleeding>13 (1.3 mg/dL)6-week mortality in Child-Pugh C[17]
Klebsiella bloodstream infection>100In-hospital mortality (OR 4.0)[8]

The evidence does not define a single "mild" versus "severe" boundary because CRP is a continuous marker that must be interpreted in context. A CRP above 10 mg/L is abnormal. Above 50 mg/L suggests significant inflammation. Above 100 mg/L is consistently associated with worse outcomes across multiple conditions. But the exact cutoff that matters depends on the disease, the patient, and the outcome being predicted.

My call: there is no universal mild-versus-severe cutoff. In practice, CRP below 10 mg/L is generally mild elevation, 10-100 mg/L is moderate, and above 100 mg/L is severe, but these are rough guides, not fixed rules. Confidence: moderate, because the evidence supports context-dependent cutoffs but does not provide a single authoritative classification.

Keep digging

Sources used 5

  1. Biomarkers in Pediatric Community-Acquired Pneumonia International Journal of Molecular Sciences (2017) narrative review Mixed

    Among traditional biomarkers, procalcitonin appears most effective for selecting bacterial cases and evaluating severity in pediatric CAP, though no precise cutoff exists; novel combined host-protein and genomic assays show promise.

    DOI: 10.3390/ijms18020447
  2. Is early time to positivity of blood culture associated with clinical prognosis in patients with Klebsiella pneumoniae bloodstream infection? Epidemiology and Infection (2023) Thin

    A retrospective study of 148 inpatients with Klebsiella pneumoniae bloodstream infection at Shanghai Tongji Hospital evaluated whether early time to positivity (TTP) of blood cultures predicts in-hospital mortality, septic shock, or ICU admission; early TTP was associated with h…

    DOI: 10.1017/s0950268823000262
  3. Serial procalcitonin levels for predicting prognosis in community‐acquired pneumonia Respirology (2016) Thin

    Serial measurements of procalcitonin (PCT) and C-reactive protein (CRP), integrated with CURB-65/PSI scores, predict prognosis and initial treatment failure in hospitalized community-acquired pneumonia, and a new scoring system combining CRP on day 1, CURB-65 on admission, and d…

    DOI: 10.1111/resp.12846
  4. C-reactive Protein Can Predict Patients with Cirrhosis at a High Risk of Early Mortality after Acute Esophageal Variceal Bleeding Internal Medicine (2019) Thin

    A retrospective, single-center study in cirrhotic patients with acute esophageal variceal bleeding identifies baseline C-reactive protein (CRP) levels, specifically CRP >= 1.3 mg/dL, as an independent predictor of higher 6-week mortality in Child-Pugh class C patients, with a si…

    DOI: 10.2169/INTERNALMEDICINE.1447-18
  5. Clinical features of pyogenic vertebral osteomyelitis and factors associated with adverse clinical outcome: a retrospective cohort study BMC Infectious Diseases (2025) Thin

    A retrospective, single-center study of 68 adults with pyogenic vertebral osteomyelitis identifies Staphylococcus aureus infection, motor weakness, and the presence of a sinus tract as independent predictors of adverse outcomes, with admission and day-7 CRP levels also predictiv…

    DOI: 10.1186/s12879-025-12118-4

Your question next

What do you want to know?

No question is too uncomfortable for the evidence. Bring yours.

Ask your question